Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v9-FR
Language French French
Date Updated 2023-10-04 2023-04-27
Drug Identification Number 02281260 02281260
Brand name ACT FLUCONAZOLE ACT FLUCONAZOLE
Common or Proper name ACT-FLUCONAZOLE 50MG ACT-FLUCONAZOLE 50MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients FLUCONAZOLE FLUCONAZOLE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 50 50
ATC code J02AC J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-01 2022-12-01
Estimated end date 2023-01-10 2023-05-30
Actual end date 2023-01-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments